We are live on ! Find out more
PS

Peter Svennilson Portfolio holdings

AUM $1.23B
1-Year Est. Return 301.34%
This Fund
S&P 500
This Quarter Est. Return
+250.59%
1 Year Est. Return
+301.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$837M
AUM Growth
+$516M
Cap. Flow
+$160M
Cap. Flow %
19.06%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RAPT
RAPT Therapeutics
RAPT
+$156M
2
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$3.71M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$304M 36.26%
16,420,829
+253,922
+2% +$3.71M
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$283M 33.81%
6,009,702
– –
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$187M 22.34%
+847,144
New +$156M
RCUS icon
4
Arcus Biosciences
RCUS
$3.55B
$35.8M 4.27%
3,540,850
– –
GRTS
5
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$27.8M 3.32%
3,102,934
– –

Similar funds

CT
CGM Trust Boston, Massachusetts $957M AUM
CAW
Cornerstone Advisors (Washington) Bellevue, Washington $936M AUM 8.77% 1-Year Est. Return
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
SFSG
Stearns Financial Services Group Greensboro, North Carolina $639M AUM 11.66% 1-Year Est. Return
KFA
Kays Financial Advisory Atlanta, Georgia $624M AUM 9.93% 1-Year Est. Return
11A
10-15 Associates Goshen, New York $516M AUM 7.62% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return

Peter Svennilson's Q4 2019 Portfolio in Review

As of Q4 2019, Peter Svennilson held 5 positions worth $837M, up 160% from $322M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Peter Svennilson deployed $160M of net new capital in Q4 2019, opening 1 new position and adding to 1 existing holding. Its largest new stake was RAPT Therapeutics: 847,144 shares worth $187M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Peter Svennilson's largest Q4 2019 buy was RAPT Therapeutics: 847,144 shares worth $187M.
  • Peter Svennilson added most to NGM Biopharmaceuticals, Inc. Common Stock in Q4 2019, an estimated $3.71M increase.
  • Peter Svennilson's ten largest holdings make up 100% of its $837M portfolio in Q4 2019.
  • Peter Svennilson opened 1 new position and closed 0 in Q4 2019.
  • Peter Svennilson's portfolio value rose 160% quarter-over-quarter to $837M.

Based on Peter Svennilson's 13F filing for Q4 2019, filed 12 Feb 2020.